The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: Radiofrequency Ablation in Treating Patients With Bone Metastases
Official Title: A Phase I/II Study of Percutaneous Radiofrequency Ablation of Bone Metastases Using CT Guidance
Study ID: NCT00026247
Brief Summary: RATIONALE: Radiofrequency ablation may be effective in decreasing pain from bone metastases. PURPOSE: Phase I/II trial to study the effectiveness of radiofrequency ablation in decreasing pain in patients who have bone metastases.
Detailed Description: OBJECTIVES: * Determine the side effects of radiofrequency ablation in patients with bone metastases. * Determine the effect of this regimen on pain in these patients. * Determine the effect of this regimen on mood in these patients. * Determine the effects of narcotic usage in patients treated with this regimen. * Determine the relationship between laboratory and imaging features of this treatment and the effects of the treatment in these patients. OUTLINE: This is a multicenter study. Patients undergo percutaneous CT-guided radiofrequency ablation directly to the metastatic lesion over approximately 12 minutes. Pain and mood are assessed at baseline, daily for 14 days after treatment, and at 1 and 3 months after treatment. Patients are followed at 1 week and then at 1 and 3 months. PROJECTED ACCRUAL: Approximately 75 patients will be accrued for this study within 12.5 months.
Minimum Age: 21 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Comprehensive Cancer Center at University of Alabama at Birmingham, Birmingham, Alabama, United States
UMASS Memorial Cancer Center - University Campus, Worcester, Massachusetts, United States
Mallinckrodt Institute of Radiology at Washington University Medical Center, Saint Louis, Missouri, United States
Radiology Consultants, Incorporated, Youngstown, Ohio, United States
Abramson Cancer Center of the University of Pennsylvania, Philadelphia, Pennsylvania, United States
Kimmel Cancer Center at Thomas Jefferson University - Philadelphia, Philadelphia, Pennsylvania, United States
Comprehensive Cancer Center at Rhode Island Hospital, Providence, Rhode Island, United States
M.D. Anderson Cancer Center at University of Texas, Houston, Texas, United States
Name: Damian E. Dupuy, MD
Affiliation: Rhode Island Hospital
Role: STUDY_CHAIR